LBI-HTA - Publications - Search - Division: Ludwig Boltzmann Institute of Health Technology Assessment
Number of items at this level: 407.

(2008): [Annual report 2007. German version].

(2008): Annual report 2007. English version.

(2006): [Annual report 2006. German version].

(2006): Annual report 2006. English version.

Abuzahra, M. and Piso, B. (2010): Kyphoplasty and vertebroplasty for the treatment of osteoporotic vertebral compression fractures- observational study. HTA-Projektbericht 25.

Abuzahra, M. and Piso, B. (2010): Classification of disease severity for neuro- and trauma rehabilitation Part 3: Status quo in Austria. HTA-Projektbericht 23c.

Abuzahra, M. and Piso, B. (2009): Classification of disease severity for neuro- and trauma rehabilitation Part 2: International experiences with quality / performance assessments and reimbursement . HTA-Projektbericht 023b.

Abuzahra, M. and Zechmeister, I. and Wild, C. (2009): International comparison of antenatal care in pregnant women. Decision Support Document 33.

Adlbrecht, C. and Breyer, E. and Gartlehner, G. and Guba, B. (2008): Selective Cell Apheresis in Inflammatory Bowel Disease. Decision Support Document 11.

Adlbrecht, C. and Radlberger, P. (2010): Cardiac contractility modulation for heart failure. Decision Support Document 15/Update 2010.

Adlbrecht, C. and Radlberger, P. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Cardiac contractility modulation for heart failure. Systematic review]. Decision Support Document 15/Update2009.

Adlbrecht, C. and Radlberger, P. and Guba, B. and Felder-Puig, R. (2008): [Cardiac contractility modulation for heart failure. Systematic review]. Decision Support Document 15.

Adlbrecht, C. and Radlberger, P. and Reiner-Theisen, I. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Drug coated balloon catheter. Systematic Review. Decision Support Document 24.

Adlbrecht, C. and Warmuth, M. (2012): Radiofrequency ablation of primary tumours of the gastrointestinal tract (colorectal and pancreatic cancer). Decision Support Document 58.

Adlbrecht, C. and Wild, C. (2010): Radionuclide therapy - 90Yttrium and 177Lutetium somatostatin analogues for the treatment of inoperable neuroendocrine tumors. Decision Support Document 40.

Adlbrecht, C. and Wild, C. (2007): [Targeted radionuclide therapy with 90Y- and 177-Lu-DOTATOC in patients with neuroendocrine tumors. HTA in hospitals]. Decision Support Document 02.

Adlbrecht, C. and Wild, C. (2007): [Photoselective vaporisation of the prostate in men with benign prostatic hyperplasia. HTA in hospitals]. Decision Support Document 01.

Baumann, M. and Grössmann, N. (2016): Pembrolizumab (Keytruda®) in previously treated advanced non-small cell lung cancer (NSCLC). DSD: Horizon Scanning in Oncology 58.

Blagojevic, S. and Hinterreiter, G. and Wild, C. (2011): Annual Report 2010. English version.

Blagojevic, S. and Winkler, R. and Wild, C. and Hinterreiter, G. (2010): Annual Report 2009. English version.

Breuer, J. and Joppi, R. and Poggiani, C. and Dabrowska, M. and Zawodnik, A. and Nachtnebel, A. (2014): Obinutuzumab (Gazyva®) for previously untreated patients with chronic lymphocytic leukaemia (CLL). DSD: Horizon Scanning in Oncology 45.

Breuer, J. and Joppi, R. and Poggiani, C. and Polkowska, M. and Nachtnebel, A. (2014): Radium-223 dichloride (Xofigo®) for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. DSD: Horizon Scanning in Oncology 44.

Breuer, J. and Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 20th Prioritisation – 3rd quarter 2014. HSO: 20th Prioritisation.

Breuer, J. and Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 19th Prioritisation – 2nd quarter 2014. HSO: 19th Prioritisation. HSO: 19th Prioritisation.

Breuer, J. and Nachtnebel, A. (2014): Implantation of endobronchial valves in patients with emphysema. Decision Support Document 20/ Update 2014.

Breuer, J. and Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 18th Prioritisation – 1st quarter 2014. HSO: 18th Prioritisation.

Breuer, J. and Nachtnebel, A. (2013): Afatinib (Giotrif®) for the treatment of EGFR TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s). DSD: Horizon Scanning in Oncology 41.

Breuer, J. and Nachtnebel, A. (2013): Enzalutamide (Xtandi®) for patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy . DSD: Horizon Scanning in Oncology 37.

Breuer, J. and Reinsperger, I. and Piso, B. (2014): Acupuncture - areas of application, current evidence and proven indications. HTA-Projektbericht 78.

Breuer, J. and Piso, B. (2013): Occupational therapy in children and adolescents. Literature review on indications, utilisation and recommendations. HTA-Projektbericht 70.

Breyer, E. (2008): Reimbursement processes – An analysis of international practice models for maintaining the health benefit baskets of solidly financed health care systems. HTA-Projektbericht 022.

Breyer, E. (2007): [Nanotechnologies in medicine: Hopes and risks]. HTA-Newsletter 60: 2-3.

Dellinger, J. and Wild, C. (2012): Universal HIV-Testing. International Recommendations and actual risk of HIV-Infections for Healthcare-Workers. Decision Support Document 61.

Emprechtinger, R. and Erdos, J. and Piso, B. (2016): Thrombectomy for ischaemic stroke: Patient characteristics, structural requirements and (differential) diagnostics. HTA-Projektbericht 87.

Erdos, J. and Mayer, J. (2015): Sphenopalatine Ganglion (SPG) stimulation of patients with therapy-resistant cluster headache. Decision Support Document 86.

Falkner, E. (2007): [Tissue engineering]. HTA-Newsletter 57: 3.

Falkner, E. and Eder, C. (2007): Health technology assessment: Evaluation of costs and benefits of therapies & methods. Int. J. Artif. Org. 2007. (In Press)

Falkner, E. and Eder, C. and Wild, C. (2007): Evaluation of regenerative medicine/tissue engineering approaches by health technolgy assessment. Regenerative Medicine 2007. (In Press)

Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Falkner, E. and Wild, C. (2007): Cell salvage for minimising perioperative allogeneic blood transfers]. HTA-Newsletter 59: 3.

Felder-Puig, R. (2008): Back pain. Diagnosis and treatment according to evidence-based guidelines - options and limitations. HTA-Projektbericht 012.

Felder-Puig, R. (2007): [The future of clinical studies?]. Österreichische Ärztezeitung (12): 48-49.

Felder-Puig, R. (2007): [Whole-body-CT screening. More harm than benefit?]. HTA-Newsletter 60: 2.

Felder-Puig, R. (2007): [Non-pharmacological interventions to prevent wandering in dementia]. HTA-Newsletter 59: 2-3.

Felder-Puig, R. (2007): [Back pain. Various methods of treatment]. HTA-Newsletter 57: 2-3.

Felder-Puig, R. (2007): [Artificial cervical discs. Recent study results]. HTA-Newsletter 55: 2.

Felder-Puig, R. (2007): [Hypertension and weight-loss. Treatment options]. HTA-Newsletter 54: 2-3.

Felder-Puig, R. (2007): [Age-related macular degeneration. Treatment and quality of life]. HTA-Newsletter 53: 2.

Felder-Puig, R. (2007): [Therapeutic conversation: The effectiveness of intensified physician-patient communication]. Newsletter der Österreichischen Gesellschaft für Public Health (01): 2.

Felder-Puig, R. (2006): [Coronary surgery, specif. PTCA: Quality and frequencies]. HTA-Newsletter 52: 3-4.

Felder-Puig, R. (2006): [Radiology in Austria. Patients’ benefit and cost-effectiveness. Editorial]. HTA-Newsletter 51: 1.

Felder-Puig, R. (2006): [Arthroplasty register: A quality assurance instrument]. HTA-Newsletter 50: 2-3.

Felder-Puig, R. (2006): [Restrictive use of Alzheimer’s drugs]. HTA-Newsletter 49: 2-3.

Felder-Puig, R. (2006): [Prosthetic intervertebral disc replacement]. HTA-Newsletter 48: 2-3.

Felder-Puig, R. and Falkner, E. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Percutaneous nucleotomy and percutaneous laser disc decompression. Systematic Review.. Decision Support Document 21b.

Felder-Puig, R. and Gyimesi, M. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Chemonucleolysis and intradiscal electrothermal therapy (IDET. Systematic Review.. Decision Support Document 21a.

Felder-Puig, R. and Mad, P. and Gartlehner, G. (2007): [Diagnostic studies]. WMW: Wiener Medizinische Wochenschrift 2007. (In Press)

Felder-Puig, R. and Mathis, S. (2008): Clavicular Fractures - A systematic review about efficacy and safety of different treatment options. HTA-Projektbericht 017.

Felder-Puig, R. and Piso, B. and Guba, B. and Gartlehner, G. (2008): [Kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures. Systematic review]. Decision Support Document 08.

Felder-Puig, R. and Turk, E. and Guba, B. and Wild, C. (2006): [Therapeutic conversation: The effectiveness of intensified physician-patient communication]. HTA-Projektbericht 01.

Fischer, S and Zechmeister-Koss, I (2012): Day Surgery. HTA- Projektbericht 64.

Fischer, S. and Kisser, A. (2015): Robot-assisted surgery: A systematic review of effectiveness and safety for elected indications and accumulating costs. HTA-Projektbericht 84.

Fischer, S. and Warmuth, M. (2012): Radiofrequency Ablation for the Treatment of Tumours of the Urogenital Tract (Renal Cell Carcinoma, Prostate Cancer and Uterine Leiomyoma). Decision Support Document 59.

Fischer, S. and Zechmeister, I. (2011): Sacral Nerve Stimulation for Fecal Incontinence. Rapid Assessment 004.

Fischer, S. and Zechmeister-Koss, I. (2015): Intrastromal corneal implants for ectatic corneal disorders. Decision Support Document 85.

Fischer, S. and Zechmeister-Koss, I. (2014): Vasoprotectives: Efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoidal diseases. HTA-Projektbericht 79.

Fischer, S. and Zechmeister-Koss, I. (2014): Costs of day surgery in Austria: An analysis of data and methods for varicose vein surgery as an example. HTA-Projektbericht 71.

Fischer, S. and Zechmeister-Koss, I. (2012): Radiofrequency Ablation for the Treatment of Head and Neck Cancer. Decision Support Document 55.

Fischer, S. and Zechmeister-Koss, I. (2012): Radiofrequency Ablation for Treatment of Benign and Malignant Lesions of Endocrine Organs (Thyroid and Adrenal Gland). Decision Support Document 56.

Fischer, S. and Zechmeister-Koss, I. (2012): Radiofrequency Ablation for the Treatment of Breast Cancer. Decision Support Document 57.

Fischer, S. and Zechmeister-Koss, I. and Huic, M. (2013): Duodeno-jejunal bypass liner (DJBL) for patients with obesity, with/without type 2 diabetes mellitus . Decision Support Document 67.

Fleischner, B. (2009): Acquisition Processes of Certain Product Groups in Hospitals - Orthopaedic and Cardiac Implants. HTA Projektbericht 38.

Frühwald, T. (2006): [Evidence-based medication in elderly patients. Editorial]. HTA-Newsletter 49: 1-2.

Fried, A. (2007): [The pharmaceutical industry puts pressure on publishers]. HTA-Newsletter 53: 1.

Fried, A. and Wild, C. (2016): Involvement of Citizens and Patients in HTA-Processes – International Experiences and Good Practice Examples. HTA-Projektbericht 86.

Fried, A. and Wild, C. (2013): Hybrid operating room. Rapid Assessment 006.

Gartlehner, G. (2009): [Internal manual. Part 2 (2nd Ed.)]. HTA-Projektbericht 06.

Gartlehner, G. (2007): [New vaccines: Horizon scanning]. HTA-Newsletter 59: 4.

Gartlehner, G. (2007): [Second-generation antidepressants]. HTA-Newsletter 57: 2.

Gartlehner, G. (2006): [Cesarean delivery on maternal request]. HTA-Newsletter 50: 2.

Gartlehner, G. and Falkner, E. and Guba, B. and Felder-Puig, R. (2008): [Optical coherence tomography. Systematic review]. Decision Support Document 13.

Gartlehner, G. and Wild, C. and Mad, P. (2008): [Systematic reviews and meta-analyses]. WMW: Wiener Medizinische Wochenschrift 158 (3-4): 127-133.

Geiger-Gritsch, S. (2010): Stent-grafting of the ascending aorta . Decision Support Document 14/Addendum 2010.

Geiger-Gritsch, S. (2010): Bendamustine (Ribomustin®/Treanda®/ Levact®) for indolent non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukaemia (CLL) and multiple myeloma. DSD: Horizon Scanning in Oncology 10.

Geiger-Gritsch, S. (2008): Horizon Scanning in Oncology - Concept Development. HTA-Newsletter 69: 3.

Geiger-Gritsch, S. (2008): Horizon Scanning in Oncology - Concept Development for the Preparation of a Horizon Scanning System in Austria . Projektbericht 14.

Geiger-Gritsch, S. (2008): Stent-graft Implantation for diseases of the ascending aorta. HTA-Newsletter 68: 2.

Geiger-Gritsch, S. (2008): [Testosterone-substitution for androgen deficiency in the ageing men]. HTA-Newsletter 66: 2.

Geiger-Gritsch, S. (2007): [Avastin® (Bevacizumab): Off-label use in cancer therapy]. HTA-Newsletter 58: 2.

Geiger-Gritsch, S. and Piso, B. and Guba, B. and Felder-Puig, R. (2008): [Stent-grafting of the ascending aorta. Systematic review]. Decision Support Document 14.

Gerdvilaite, J. and Nachtnebel, A. (2011): Disinvestment. Overview of disinvestment experiences and challenges in selected countries. HTA-Projektbericht 57.

Gottardi, R. and Wild, C. (2011): Percutaneous aortic valve replacement (with a side note on hybrid operating rooms). Decision Support Document 18/Update 2011.

Grössmann, N. and Baumann, M. (2016): Ofatumumab (Arzerra®) as maintenance therapy in patients with relapsed chronic lymphocytic leukaemia (CLL). DSD: Horizon Scanning in Oncology 57.

Grössmann, N. and Wild, C. (2016): Horizon Scanning in Oncology 26th Prioritisation – 1st quarter 2016. HSO: 26th Prioritisation.

Grössmann, N. and Wild, C. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 25th Prioritisation – 4th quarter 2015. HSO: 25th Prioritisation.

Gregor-Patera, N. and Schader , M. and Wild, C. (2016): Non-interventional studies (NIS) in Austria. A systematic analysis. Rapid Assessment 007c.

Groth, S. (2007): [HPV immunisation and cervical cancer prevention. Editorial]. HTA-Newsletter 54: 1.

Guba, B. (2008): [Systematic literature search]. WMW: Wiener Medizinische Wochenschrift 158 (01-02): 62-69.

Guba, B. (2007): The role of the information specialist in the context of health technology assessment. Workshop of the European Association for Health Information and Libraries. Krakow, 12.-15.09.2007.

Guba, B. (2007): [Library services in university portals: Outlook and risks]. VÖB-Mitteilungen 60 (2): 30-38.

Guba, B. (2006): [Anti-aging medicine: What´s behind it?]. HTA-Newsletter 52: 4.

Guba, B. (2006): [Libraries and portals - a survey]. Medizin Bibliothek Information 6 (2).

Guba, B. (2006): [Information management at the CRD (York) and the LBI (Vienna)]. Jour fixe of LBI-HTA. Vienna, 21.06.2007. (Unpublished)

Gugerbauer, J. and Warmuth, M. (2011): Radiofrequency ablation for hepatocellular carcinoma and colorectal liver metastases. Decision Support Document 049.

Gyimesi, M. and Piso, B. and Tüchler, H. (2010): Outpatient cardiac rehabilitation. Part 3a: Retrospective cohort study (with/without phase III rehabilitation) - explorative analysis and developing of an evaluation plan. HTA-Projektbericht 31a.

Hepperger, C. and Nachtnebel, A. (2014): Bevacizumab (Avastin®) for platinum-resistant recurrent, epithelial ovarian, fallopian tube or primary peritoneal cancer. DSD: Horizon Scanning in Oncology 48.

Hinterreiter, G. (2008): Medical self-test kits - Expectations & actual benefit. HTA-Newsletter 72:3.

Hinterreiter, G. (2008): Incisional hernias - A comparison of different surgery methods. HTA-Newsletter 70: 5.

Hinterreiter, G. and Wild, C. (2011): Annual Report 2010. German Version.

Hinterreiter, G. and Wild, C. (2009): Annual report 2008. English version.

Hinterreiter, G. and Wild, C. (2009): [Annual report 2008. German version] .

Hinterreiter, G. and Wild, C. and Blagojevic, S. (2010): Annual Report 2009. German version.

Hintringer, K. (2012): Bortezomib (Velcade®) as consolidation or maintenance therapy after autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma. DSD: Horizon Scanning in Oncology 29.

Hintringer, K. (2012): Romidepsin (Istodax®) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) after prior systemic therapy. DSD: Horizon Scanning in Oncology 25.

Hintringer, K. (2012): Brentuximab (Adcetris®) for the treatment of relapsed Hodgkin's lymphoma (HL) or relapsed systemic anaplastic large cell lymphoma (sALCL). DSD: Horizon Scanning in Oncology 26.

Hintringer, K. (2012): Quality Appraisal of Written Consumer Health Information for Patients with Chronic Myeloid Leukaemia (CML) . HTA-Projektbericht 52.

Hintringer, K. (2011): Dasatinib (Sprycel®) for the 1st-line treatment of Philadelphia-chromosome positive chronic myeloid leukemia in the chronic phase. DSD: Horizon Scanning in Oncology 17.

Hintringer, K. (2011): Nilotinib (Tasigna®) for the 1st-line treatment of Philadelphia chromosome positive chronic myeloid leukemia in the chronic phase. DSD: Horizon Scanning in Oncology 15.

Hintringer, K. (2010): Pazopanib (Votrient®) for the treatment of locally advanced and/or metastatic renal cell carcinoma. DSD: Horizon Scanning in Oncology 13.

Hintringer, K. (2010): Panitumumab (Vectibix ®) for the first-line treatment of metastatic colorectal cancer. DSD: Horizon Scanning in Oncology 11.

Hintringer, K. (2010): Plerixafor (Mozobil ®) for autologous stem cell transplantation in patients with lymphoma and multiple myeloma. DSD: Horizon Scanning in Oncology 08.

Hintringer, K. (2010): Trabectedin (Yondelis ®) for second-line recurrent platinum-sensitive ovarian cancer. DSD: Horizon Scanning in Oncology 07.

Hintringer, K. (2009): Cetuximab (Erbitux®) in EGFR-expressing Non-Small Cell Lung Cancer. DSD: Horizon Scanning in Oncology 02.

Hintringer, K. and Warmuth, M. (2013): Percutaneous transluminal coronary angioplasty (PTCA) with paclitaxel-coated drug-eluting balloon (DEB). Update 2013. Decision Support Document 24/ Update 2013.

Hintringer, K. and Wild, C. (2009): Bioresonance for allergiges, atopic dermatitis, non-organic gastrointestinal complaints, pain and rheumatic diseases. Decision Support Document 31.

Hintringer, K. and Wild, C. (2009): Colon Hydrotherapy for defecation disorders. Systematic Review. Decision Support Document 32.

Janatzek, S. and ThomasS, S. and Mad, P. (2010): Percutaneous Repair of mitral regurgitation with the MitraClip . Decision Support Document 41.

Jeitler, K. and Semlitsch , T. (2012): Everolimus (Afinitor® or Votubia®) in combination with exemestane in postmenopausal women with oestrogen receptor positive, HER2-negative locally advanced or metastatic breast cancer who are refractory to letrozole or anastrozole. DSD: Horizon Scanning in Oncology 32.

Jeitler, K. and Semlitsch, T. (2012): Bevacizumab (Avastin®) in combination with chemotherapy in previously treated metastatic breast cancer. DSD: Horizon Scanning in Oncology 27.

Johansson, T. and Mathis, S. (2010): Laser angioplasty of coronary arteries . Decision Support Document 39.

Johansson, T. and Wild, C. (2009): Telemedicine in Stroke Management. Systematic Review. HTA-Projektbericht 029.

Joppi, R and Nachtnebel, A. (2012): Trametinib for advanced or metastatic BRAF V600 mutation-positive melanoma. DSD: Horizon Scanning in Oncology 34.

Joppi, R. and Nachtnebel, A. (2012): Ipilimumab (Yervoy®) for the first-line therapy of advanced/metastatic cutaneous melanoma . DSD: Horizon Scanning in Oncology 30.

Joppi, R. and Wild, C. (2012): Vemurafenib for patients with BRAF V600E mutation positive advanced/metastatic melanoma. DSD: Horizon Scanning in Oncology 23.

Künzl, M. and Wild, C. and Mathis, S. and Johansson, T. (2009): Autologous Chondrocyte Implantation. Systematic Review. Decision Support Document 34.

Kirisits, A. and Wild, C. (2012): Efficacy of Hyperthermia Treatment in combination with radio- or chemotherapy in Breast-, Bladder-, Cervix Carcinoma and Soft Tissue Sarcoma patients. Update 2012. Decision Support Document 36 / Update 2012.

Kis, A. and Wild, C. and Bodamer, O. (2008): Enzyme Replacement Therapy for Lysosomal Storage Diseases. Decision Support Document 19.

Kisser, A. and Kirisits, A. (2015): Endovascular embolization of unruptured intracranial aneurysms with flow diverters. Decision Support Document 83.

Kisser, A. and Kirisits, A. (2014): Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of peritoneal carcinomatosis . Decision Support Document 74.

Kisser, A. and Mayer, J. and Wild, C. (2014): Opportunities and strategies to drive appropriate use of MRI in Austria. HTA-Projektbericht 80.

Kisser, A. and Zechmeister-Koss, I. (2014): Procedural guidance for the systematic evaluation of biomarker tests. Decision Support Document 77.

Kisser, A. and Zechmeister-Koss, I. (2013): P16/Ki-67 Dual Stain in the triage of PAPIII/IIID cytology in cervical cancer screening . HTA-Projektbericht 72.

Klepp, B. (2006): [Drug advertising: Law versus reality. Editorial]. HTA-Newsletter 50: 1.

Knapp, M. and Mc Daid, D. and Amaddeo, F. and Zechmeister, I. (2007): Financing Mental Health Care in Europe. Journal of Mental Health 16 (02): 167-180.

Korencan, A. (2007): [HER2 diagnostics in breast cancer]. HTA-Newsletter 55: 3-4.

Korencan, A. (2007): [Diagnosis of cytomegalovirus disease in immunocompromised patients]. HTA-Newsletter 53: 4.

Korencan, A. and Guba, B. and Wild, C. (2007): Testing for HER2 positive breast cancer. Challenge for improvement of current conditions and practice. HTA-Projektbericht 08.

Krüger, L.J. and Wild, C. (2013): Evidence requirements for the authorization and reimbursement of high-risk medical devices in the USA, Europe, Australia and Canada: An analysis of seven high-risk medical devices. HTA-Projektbericht 73.

Krebs, E.E. and Gaynes, B.N. and Gartlehner, G. and Hansen, R.A. and Thieda, P. and Morgan, L.C. and de Veaugh-Geiss, A. and Lohr, K.N. (2008): Treating the physical symptoms of depression with second-generation antidepressants: A systematic review and metaanalysis. Psychosomatics: The Journal of Consultation and Liaison Psychiatry 49 (3): 191-198.

Kvas, E. (2006): [Drug eluting stents in comparison to uncoated stents in the treatment of cardiopathy]. Rapid Assessment LBI-HTA 01.

Langer, T. (2007): [Environmental safety of drugs]. HTA-Newsletter 57: 1.

Langer, T. (2006): [Stem cell transplantation for acute leukemia]. HTA-Newsletter 52: 2-3.

Langer, T. (2006): [Role of neuroimaging for headache]. HTA-Newsletter 51: 3-4.

Langer, T. (2006): [Cochlear implants]. HTA-Newsletter 50: 4.

Langer, T. (2006): [Hip protectors for preventing hip fractures]. HTA-Newsletter 49: 4.

Langer, T. (2006): [Bypass materials in vascular surgery]. HTA-Newsletter 48: 3-4.

Langley, T. and Geiger, W. and Gartlehner, G. (2008): Aromatherapy for pain relief and psychological problems. Systematic review. Decision Support Document 16.

Langley, T. and Geiger, W. and Gartlehner, G. (2008): Bach Flower Remedies for pain relief and psychological problems. Systematic review. Decision Support Document 17.

Mad, P. (2007): [Health services research: Service improvement]. HTA-Newsletter 60: 4.

Mad, P. (2007): [Photodynamic therapy in the palliative treatment of malignant oesophageal stenosis]. HTA-Newsletter 58: 3-4.

Mad, P. (2007): [Telemonitoring for patients with chronic heart failure]. HTA-Newsletter 56: 4.

Mad, P. (2007): [Screening for Glaucoma]. HTA-Newsletter 55: 2-3.

Mad, P. (2007): [Robotic surgery in urology: Prostate interventions]. HTA-Newsletter 54: 4.

Mad, P. (2007): Drug Eluting Stents (DES): Safety aspects. HTA-Newsletter 53: 2-3.

Mad, P. (2006): [Computed tomographic angiography for coronary artery evaluation]. HTA-Newsletter 48: 4.

Mad, P. and Falkner, E. and Guba, B. and Gartlehner, G. (2008): [Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction in patients with congenital heart defects. Systematic review]. Decision Support Document 10.

Mad, P. and Felder-Puig, R. and Gartlehner, G. (2007): [Randomized controlled trials]. WMW: Wiener Medizinische Wochenschrift April 2007. (In Press)

Mad, P. and Geiger-Gritsch, S. and Mittermayr, T. and Wild, C. (2009): Tocolysis in preterm labour - A systematic review of evidence-based guidelines, effectiveness and health economic evaluations. HTA-Projektbericht 030.

Mad, P. and Johansson, T. and Guba, B. and Wild, C. (2008): Clinical Pathways: Systematic Review of outcome parameters and effectiveness. HTA-Projektbericht 16.

Mad, P. and Langer, T. and Guba, B. and Kvas, E. and Reichelt, C. and Adlbrecht, C. and Wild, C. (2007): [Role and positioning of university outpatient departments]. HTA-Projektbericht 05.

Mad, P. and Wild, C. (2007): [Photodynamic therapy for the treatment of malignant stenosis in the alimentary tract. HTA in hospitals]. Decision Support Document 03.

Mathis, S. (2007): [Interstitial brachytherapy in the treatment of localised prostate cancer]. HTA-Newsletter 57: 4.

Mathis, S. and Eisner, W. (2010): Gamma Knife versus adapted linear accelerators: A comparison of two radiosurgical applications . HTA-Projektbericht 47.

Mathis, S. and Garbaty , T. and Czeczot , J. and Maran , P.R. and Alberti, C. and Nachtnebel, A. (2011): Eribulin (Halaven®) as third- or late- line mono-therapy for advanced/metastatic breast cancer. DSD: Horizon Scanning in Oncology 18.

Mathis, S. and Gartlehner, G. (2008): [Cohort studies]. WMW: Wiener Medizinische Wochenschrift 158 (05-06): 174-179.

Mathis, S. and Johansson, T. (2010): Hyperthermia. Decision Support Document 36.

Mathis, S. and Johansson, T. and Mad, P. and Mittermayr, T. (2011): Mechanical percutaneous transluminal cerebral clot retrieval devices in acute ischemic stroke: Systematic Review on efficacy and safety. Decision Support Document 46.

Mathis, S. and Wild, C. (2008): [Clinical and health economic registries in the field of cardiovascular, spinal and neurologic diseases. Methods and good practice strategies]. HTA-Projektbericht 11.

Mathis, S. and Wild, C. and Piso, B. and Piribauer, F. (2009): Evidence supported health services planning. HTA Projektbericht 021.

Mathis, S. and Winkler, R. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Selective IgG Apheresis for ABO-incompatible kidney transplantation. Systematic Review. Decision Support Document 25.

Mathis-Edenhofer, S. and Kirisits, A. (2012): Sling suspension in male urinary incontinence. Decision Support Document 60.

Mathis-Edenhofer, S. and Schramm, F. and Wild, C. (2012): Re-orientation of the Austrian parent-child preventive health care programme, Part VII: The potential of an electronic implementation. HTA- Projektbericht 54 .

Mayer, J. (2015): Balloon Eustachian Tuboplasty for the treatment of Eustachian tube dysfunction - German short version and update of the correspondent EUnetHTA assessment. Decision Support Document 91.

Mayer, J. and Nachtnebel, A. (2013): Identification of ineffective interventions and technologies: Existing models and their implementation. HTA-Projektbericht 68.

Metz, S. and Mittermayer, H. (2007): [Antibiotic resistance: A challenge for health policy. Editorial]. HTA-Newsletter 58: 1.

Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 21st Prioritisation – 4th quarter 2014. HSO: 21st Prioritisation.

Nachtnebel, A. (2013): Pomalidomide (Pomalidomide Celgene/Pomalyst®) for the ≥ 3rd-line therapy of patients with relapsed and refractory multiple myeloma. DSD: Horizon Scanning in Oncology 39.

Nachtnebel, A. (2012): Pertuzumab (Omnitarg/Perjeta®) for the first-line therapy of metastatic HER2 positive breast cancer. DSD: Horizon Scanning in Oncology 31.

Nachtnebel, A. (2012): Erlotinib (Tarceva®) for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer with EGFR activating mutations. DSD: Horizon Scanning in Oncology 22.

Nachtnebel, A. (2011): Second-line chemotherapy with cabazitaxel (Jevtana®) for the treatment of castration-resistant metastatic prostate cancer. DSD: Horizon Scanning in Oncology 16.

Nachtnebel, A. (2011): Ipilimumab for pre-treated patients with advanced/metastatic melanoma . DSD: Horizon Scanning in Oncology 14.

Nachtnebel, A. (2010): Evaluation of diagnostic technologies – background, challenges, methods. HTA-Projektbericht 36.

Nachtnebel, A. (2010): Endobronchial valve implantation for emphysema. Decision Support Document 20/Update 2010.

Nachtnebel, A. (2010): Lapatinib ditosylate (Tyverb/Tykerb®) as first-line therapy for the treatment of advanced/metastatic breast cancer. DSD: Horizon Scanning in Oncology 09.

Nachtnebel, A. (2010): Gefitinib (Iressa®) for the first-line treatment of non-small cell lung cancer . DSD: Horizon Scanning in Oncology 06.

Nachtnebel, A. (2009): Azacitidine (Vidaza®) for the treatment of myelodysplastic syndromes. DSD: Horizon Scanning in Oncology 01.

Nachtnebel, A. (2009): Everolimus (Afinitor®) for advanced/metastatic kidney cancer. DSD: Horizon Scanning in Oncology 03.

Nachtnebel, A. (2009): Ibritumomab tiuxetan (Zevalin®) as consolidation therapy after first remission in patients with follicular lymphoma. DSD: Horizon Scanning in Oncology 05.

Nachtnebel, A. and Breuer, J. (2014): Ibrutinib (Imbruvica®) for relapsed or refractory chronic lymphocytic leukaemia. DSD: Horizon Scanning in Oncology 47.

Nachtnebel, A. and Felder-Puig, R. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Injektion therapies and radiofrequency for the treatment of chronic back pain. Systematic Review. Decision Support Document 22.

Nachtnebel, A. and Maran , P.R. and Alberti, C. and Garbaty , T. and Czeczot , J. (2012): Lenalidomide (Revlimid®) for the treatment of low /intermediate-1 risk myelodysplastic syndrome with chromosome 5q deletion. DSD: Horizon Scanning in Oncology 28.

Nachtnebel, A. and Mathis, S. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Image guided radiotherapy using cone-beam computed tomography. Systematic Review.. Decision Support Document 26.

Nachtnebel, A. and Polkowska, M. and Czeczot , J. and Joppi, R. and Poggiani, C. (2013): Trastuzumab emtansine (Kadcyla™) for previously treated patients with HER2-positive advanced/metastatic breast cancer . DSD: Horizon Scanning in Oncology 36.

Nachtnebel, A. and Reinsperger, I. (2012): Percutaneous repair of mitral regurgitation with the MitraClip® . Decision Support Document 41 / Update 2012.

Nachtnebel, A. and Sotti, G. and Vitale, A. and Perrini, MR. (2011): Selective internal radiotherapy using yttrium-90 microspheres for primary and secondary liver malignancies. German version. Decision Support Document 47.

Nachtnebel, A. and Sotti, G. and Vitale, A. and Perrini, MR. (2011): Selective internal radiotherapy using yttrium-90 microspheres for primary and secondary liver malignancies. English version. Decision Support Document 47.

Nachtnebel, A. and Ujeyl, M. (2015): Nivolumab (Nivolumab BMS®) for the second-line therapy of metastatic squamous non-small cell lung cancer. DSD: Horizon Scanning in Oncology 53.

Nachtnebel, A. and Warmuth, M. (2013): Percutaneous coronary intervention for chronic total occlusion. Decision Support Document 64.

Nagele, M. (2006): [Computed tomographic colonography (CTC) for colon cancer screening]. HTA-Newsletter 51: 4.

Naimer, Ch. and Piso, B. (2015): Outpatient neurological rehabilitation: goal attainment in stroke patients. Systematic review. Decision Support Document 92.

Pammer, C. and Abuzahra, M. and Wild, C. (2009): Classification of disease severity for neuro- and trauma rehabilitation Part 1: instruments for stroke and traumatic brain injury . HTA-Projektbericht 023a.

Patera, N. (2013): Screening for Colorectal Cancer. Part 3: Status of screening-activities and quality assurance of screening-colonoscopy. HTA-Projektbericht 41c.

Patera, N. (2011): Quality of care in oncology and its measurement. HTA-Projektbericht 49a.

Patera, N. (2011): Strengthening the evidence base for a learning health system - Inspirations from good practice for capacity building in health services research and public health research. HTA-Projektbericht 48.

Patera, N. (2010): Screening for Colorectal Cancer. Part 1: Screening-Tests and Project Design. (2nd revised edition). HTA-Projektbericht 41a.

Patera, N. and Piso, B. (2012): Occupational Therapy Part IV for Dementia and Part V for Depression. HTA- Projektbericht 60.

Patera, N. and Reinsperger, I. (2013): Treatment by clinical psychologists. Part I: Overview of training requirements and systematic stakeholder analysis on delineation of areas of responsibility and treatment methods. HTA-Projektbericht 69a.

Patera, N. and Schumacher, I. (2012): Screening for Colorectal Cancer. Part 1: Screening Tests and Program Design (3. updated edition). HTA-Projektbericht 41a.

Patera, N. and Schumacher, I. (2012): Screening for Colorectal Cancer. Part 2: Health economic evaluations and cost dynamics (2. updated edition). HTA-Projektbericht 41b.

Patera, N. and Warmuth, M. (2011): Training therapy in physical medicine: Rapid systematic review. Decision Support Document 51.

Patera, N. and Wild, C. (2014): Assessment – APPRAISAL – Decision: (Good) Practice examples and recommendations. Decision Support Document 72.

Patera, N. and Wild, C. (2012): Generic indicators for process quality in oncological care: A compendium. HTA-Projektbericht 49b.

Patera, N. and Wild, C. (2009): Status quo mammography screening: evaluation results from organised programs. HTA-Projektbericht 035.

Piso, B. (2008): Outpatient Cardiac Rehabilitation Part I- Evaluation and Indicators Part II- Comparative analysis of various rehabilitation models and Phase III. HTA-Projektbericht 15.

Piso, B. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Stent-grafting of the ascending aorta. Systematic review]. Decision Support Document 14/Update2009.

Piso, B. and Gyimesi, M. and Tüchler, H. (2010): Outpatient cardiac rehabilitation. Part 3b: Retrospective cohort study (with/without phase III rehabilitation) - application of the evaluation plan. HTA-Projektbericht 31b.

Piso, B. and Mathis, S. (2010): Kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures. Decision Support Document 08/Update 2010.

Piso, B. and Mathis, S. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Pumpless extracorporeal lung assist (PECLA). Systematic Review.. Decision Support Document 27.

Piso, B. and Reinsperger, I. (2015): Vaccination against human papillomavirus (HPV). Decision-aid for young women and girls. Decision Support Document 79.

Piso, B. and Reinsperger, I. (2014): Sustainability of inpatient psychiatric rehabilitation for adults: systematic review. HTA-Projektbericht 75.

Piso, B. and Tüchler, H. (2012): Outpatient cardiac rehabilitation. Part V: Study protocol "Multi-centre, prospective cohort study with two control groups (with/without phase III)". Decision Support Document 50.

Piso, B. and Tüchler, H. (2011): Outpatient cardiac rehabilitation part IV: Options für a prospective study. Decision Support Document 048.

Piso, B. and Wild, C. (2008): Rational Vaccination Policies - decision support. Review of International Literature for "Rational" Vaccination Policies. Rapid Assessment LBI-HTA 03.

Piso, B. and Wild, C. and Winkler, R. and Warmuth, M. (2011): Reorientation of the Austrian parent-child preventive care programme. Part IV: Synthesis of parts I-III, recommendations. HTA-Projektbericht 045d.

Poggiani, C. and Hintringer, K. (2012): Axitinib (AG013736, Inlyta®) for the second-line treatment of metastatic renal cell carcinoma (mRCC) . DSD: Horizon Scanning in Oncology 21.

Poggiani, C. and Nachtnebel, A. (2012): Lenalidomide (Revlimid®) for the first-line therapy of transplant-ineligible patients with multiple myeloma. DSD: Horizon Scanning in Oncology 33.

Pramesberger, C. and Adlbrecht, C. and Guba, B. and Felder-Puig, R. (2008): [New minimally invasive methods in the treatment of stress urinary incontinence. Systematic review]. Decision Support Document 06.

Puig, S. and Felder-Puig, R. (2006): [Evidence-based radiology: A new approach to evaluate the clinical practice of radiology]. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 178 (7): 671-679.

Puig, S. and Staudenherz, A. and Felder-Puig, R. and Paya, K. (2008): Imaging of appendicitis in children and adolescents: Useful or useless? A comparison of imaging techniques and a critical review of the current literature. Seminars in Roentgenology 43 (1): 22-28.

Radlberger, P. (2007): [Mass spectrometry for metabolic diseases in newborns]. HTA-Newsletter 60: 3-4.

Radlberger, P. (2007): [Wound treatment: Vacuum-assisted closure]. HTA-Newsletter 56: 3.

Radlberger, P. (2007): [Participation in screening programmes]. HTA-Newsletter 55: 4.

Radlberger, P. (2007): [Genotyping for Cytochrome P450 Polymorphisms]. HTA-Newsletter 53: 3.

Radlberger, P. (2006): [Predictive genetic diagnostics: Testing for breast cancer]. HTA-Newsletter 52: 2.

Radlberger, P. (2006): [Magnetic resonance imaging in patients with breast cancer]. HTA-Newsletter 51: 2-3.

Radlberger, P. and Wild, C. and Guba, B. (2007): [Mammography screening. Evidence-based evaluation of mammography-based breast cancer screening programmes]. HTA-Projektbericht 07.

Radlberger, P. and Zechmeister, I. (2011): IFEDH - Innovative Framework for Evidence-based Decisionmaking in Health Care – Standardised working in HTA (WP 1.2). HTA-Projektbericht 044a.

Radlberger, P. and Zechmeister, I. (2010): Screening for Colorectal Cancer. Part 2: Health economic evaluations and developments of costs. HTA-Projektbericht 41b.

Reichel, M. and Zechmeister-Koss, I. (2012): Renal denervation in patients with essential hypertension . Decision Support Document 45 / Update 2012.

Reinsperger, I. and Nachtnebel, A. (2014): Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation (1st Update 2014). Decision Support Document 44/ Update 2014.

Reinsperger, I. and Patera, N. and Piso, B. (2013): Treatment by clinical psychologists. Part II: Literature overview on methods of treatment and areas of application. HTA-Projektbericht 69b.

Reinsperger, I. and Piso, B. (2015): Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation (2nd Update 2015). Decision Support Document 44/ 2. Update 2015.

Reinsperger, I. and Piso, B. (2015): Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB) (1st Update 2015). Decision Support Document 68/ 1. Update 2015.

Reinsperger, I. and Piso, B. (2014): Re-orientation of the Austrian parent-child preventive care programme, part X: further development of the mother-child-pass.. Decision Support Document 78.

Reinsperger, I. and Piso, B. (2012): Occupational Therapy Part III. Occupational therapy for patients after stroke. HTA- Projektbericht 59.

Reinsperger, I. and Winkler, R. and Piso, B. (2013): Re-orientation of the Austrian parent-child preventive care programme. Part IX: Recommendations from evidence-based guidelines for screening measures during pregnancy and early childhood (0-6 yrs.) . HTA-Projektbericht 62.

Rothschedl, E. and Joppi, R. and Poggiani, C. (2014): Idelalisib (Zydelig®) in addition to rituximab for the treatment of relapsed chronic lymphocytic leukaemia. DSD: Horizon Scanning in Oncology 49.

Rothschedl, E. and Nachtnebel, A. (2016): Bevacizumab (Avastin®) in addition to standard chemotherapy for the first-line treatment of ovarian cancer. DSD: Horizon Scanning in Oncology 56.

Rothschedl, E. and Nachtnebel, A. (2015): Pembrolizumab (Keytruda®) for the treatment of advanced melanoma. DSD: Horizon Scanning in Oncology 55.

Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 24th Prioritization – 3rd quarter 2015. HSO: 24th Prioritisation.

Rothschedl, E. and Nachtnebel, A. (2015): Bevacizumab (Avastin®) in combination with chemotherapy as second-line therapy for HER2-negative, locally recurrent or metastatic breast cancer that has progressed after first-line treatment with bevacizumab plus chemotherapy. DSD: Horizon Scanning in Oncology 51.

Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology 23rd Prioritization – 2nd quarter 2015. HSO: 23rd Prioritisation.

Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 22nd Prioritisation – 1st quarter 2015. HSO: 22nd Prioritisation.

Rothschedl, E. and Nachtnebel, A. (2015): Defibrotide for the treatment and prophylaxis of hepatic veno-occlusive disease. Decision Support Document 84.

Rothschedl, E. and Nachtnebel, A. (2014): Bevacizumab (Avastin®) as maintenance therapy after first progression on bevacizumab for patients with advanced colorectal carcinoma. DSD: Horizon Scanning in Oncology 46.

Rothschedl, E. and Nachtnebel, A. (2013): Regorafenib (Stivarga®) for heavily pretreated patients with metastatic colorectal cancer (mCRC). DSD: Horizon Scanning in Oncology 40.

Rothschedl, E. and Nachtnebel, A. (2013): Aflibercept (Zaltrap®) in addition to FOLFIRI for the 2nd line therapy of metastatic colorectal cancer. DSD: Horizon Scanning in Oncology 38.

Said, H. (2007): [Relationship between health and health care costs. Editorial]. HTA-Newsletter 55: 1.

Schiller-Frühwirth, I. and Johansson, T. and Göbl, M. and Reiselhuber, S. and Wild, C. (2009): Folic acid fortification of flour in Austria - Risks and benefits. HTA-Projektbericht 020.

Schiller-Frühwirth, I. and Wild, C. (2012): Intraoperative radiotherapy for primary breast cancer. Decision Support Document 23 / Update 2012.

Schiller-Frühwirth, I. and Wild, C. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Intraoperative radiotherapy for primary breast cancer. Systematic Review.. Decision Support Document 23.

Schott, G. (2010): Trastuzumab (Herceptin®) in addition to standard chemotherapy as first-line therapy for advanced gastric cancer. DSD: Horizon Scanning in Oncology 12.

Schumacher, I. (2009): Artificial food colours and Hyperactivity. HTA-Projektbericht 034.

Schumacher, I. and Piso, B. (2012): Occupational therapy. Part I: Status quo in Austria and part II: Occupational therapy for rheumatoid arthritis. HTA- Projektbericht 56.

Schumacher, I. and Piso, B. (2012): Reorientation of the Austrian parent-child preventive care programme. Part V: Measures to reduce preterm birth. HTA-Projektbericht 50.

Schumacher, I. and Warmuth, M. (2011): Exercise therapy (Krankengymnastik/Heilgymnastik) in physical medicine: Rapid systematic review. Decision Support Document 52.

Schumacher, I. and Zechmeister, I. (2011): Impact from HTA-research for the Austrian health care system. Part 2: Results of the empirical survey. HTA-Projektbericht 37b.

Schumacher, I. and Zechmeister, I. (2010): Impact of HTA-research in Austria for the health care system. Part 1: Overview - Update. HTA-Projektbericht 37a.

Semlitsch , T. and Jeitler, K. (2013): Crizotinib (Xalkori®) for the treatment of anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) . DSD: Horizon Scanning in Oncology 35.

Semlitsch, T. and Zengerer, A. and Jeitler, K. (2014): Nab-Paclitaxel (Abraxane®) as first-line therapy for metastatic adenocarcinoma of the pancreas. DSD: Horizon Scanning in Oncology 43.

Semlitsch, T. and Zengerer, A. and Jeitler, K. (2013): Dabrafenib (Tafinlar®) in previously untreated subjects with BRAF mutation-positive advanced (stage III) or metastatic (stage IV) melanoma. DSD: Horizon Scanning in Oncology 42.

Siebenhofer-Kroitzsch, A. (2006): [Insulin analogues: Price and treatment strategy. Editorial]. HTA-Newsletter 52: 1.

Stumpner, T. (2013): Percutaneous transcatheter closure of prosthetic mitral and aortic paravalvular leaks. Decision Support Document 70.

Thomas, S. and Janatzek, S. and Geiger-Gritsch, S. and Preuß, C. (2009): Retroluminal transobturatoric reposition sling for the treatment of stress urinary incontinence in men. Systematic Review.. Decision Support Document 30.

Ujeyl, M. (2012): Everolimus (Afinitor®) for the treatment of unresectable or metastatic neuroendocrine tumours of pancreatic origin. DSD: Horizon Scanning in Oncology 24.

Ujeyl, M. and Nachtnebel, A. (2015): Nivolumab (Opdivo®) as single-agent first-line therapy for unresectable or metastatic melanoma. DSD: Horizon Scanning in Oncology 50.

Van der Vossen, A. (2013): Marketing Authorisations under Exceptional Circumstances for Oncology Drugs . HTA- Projektbericht 65.

Velasco-Garrido, M. and Busse, R. (2007): [Health baskets in 9 countries of the EU. Editorial]. HTA-Newsletter 56: 1.

Warmuth, M. (2013): Endovascular repair of aortic aneurysms. Decision Support Document 69.

Warmuth, M. (2009): Rituximab (Rituxan®/MabThera®) for the first- and second-line treatment of chronic lymphocytic leukaemia. DSD: Horizon Scanning in Oncology 04.

Warmuth, M. and Johansson, T. (2010): High-intensity focussed ultrasound (HIFU) for the treatment of prostate cancer. Decision Support Document 37.

Warmuth, M. and Mad, P. and Piso, B. and Schumacher, I. and Wild, C. (2011): Reorientation of the Austrian parent-child preventive care programme. Part I: Epidemiology - Frequency of risk factors and disease during pregnancy and early childhood. HTA-Projektbericht 045a.

Warmuth, M. and Mad, P. and Wild, C. (2009): Haemocomplettan® P alone or in combination with Fibrogammin® P in acquired hypofibrinogenemia. HTA-Projektbericht 039.

Warmuth, M. and Nachtnebel, A. (2012): Radiofrequency ablation of tumours of the lung and mediastinal lymph nodes. Decision Support Document 53.

Warmuth, M. and Nachtnebel, A. (2012): Radiofrequency ablation of bone tumours (osteoid-osteoma and osseous metastases). Decision Support Document 54.

Warmuth, M. and Schumacher, I. (2012): Extracorporeal shock wave therapy (ESWT) in non-union or delayed union of fractures. Decision Support Document 62.

Warmuth, M. and Schumacher, I. (2011): Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation . Decision Support Document 44.

Warmuth, M. and Schumacher, I. and Maringer, B. (2011): Efficacy and safety of treatment options for varicose veins. HTA-Projektbericht 051.

Warmuth, M. and Stumpner, T. (2013): Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB). Decision Support Document 68.

Warmuth, M. and Stumpner, T. (2012): Therapeutic hypothermia (TH). Decision Support Document 63.

Wegman, M. and Thomas, S. and Deuber, HJ. (2011): Renal denervation in patients with essential hypertonia. Decision Support Document 45.

Wild, C. (2015): Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation (MitraClip®, Carillon®, NeoChord DS1000). German short version of the correspondent EUnetHTA assessment. Decision Support Document 93.

Wild, C. (2015): Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenoses. Decision Support Document 89.

Wild, C. (2015): Hadron therapy in children: evidence synthesis for 15 paediatric tumours. Report based on Belgian (KCE) HTA report. Decision Support Document 88.

Wild, C. (2013): Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM) . Decision Support Document 71.

Wild, C. (2013): Repair of cartilage defects via matrix-associated autologous chondrocyte immigration. Decision Support Document 66.

Wild, C. (2012): Avastin for Age-related Macular-Degeneration. Evidence synthesis after CATT, IVAN, MANTA. Rapid Assessment 005.

Wild, C. (2012): Cell therapy for urinary stress incontinence. Decision Support Document 06 / Update 2012.

Wild, C. (2010): Percutaneous aortic valve replacement. Decision Support Document 18/Update 2010.

Wild, C. (2008): Polymorphism-screening: genetic testing for predisposition - guidance for technology assessment. Poiesis & Praxis: International Journal of Ethics of Science and Technology Assessment 05 (01): 1-14.

Wild, C. (2007): [Resource allocation in paediatrics]. 1st Annual Meeting of Childhood Medicine. Salzburg, 19.-20.10.2007.

Wild, C. (2007): [FDA: Safety warning on erythropoietin]. ÖKZ: Österreichische Krankenhauszeitung 48 (07).

Wild, C. (2007): [FDA: Safety warning on erythropoietin]. HTA-Newsletter 58: 4.

Wild, C. (2007): [Health technology assessment in Austria]. UMIT-PH course. Hall/Tyrol, 17.04.2007.

Wild, C. (2007): [Health technology assessment]. European Forum Alpbach. Vienna, 28.03.2007.

Wild, C. (2007): [Drug eluting stents. Status quo]. ÖKZ: Österreichische Krankenhauszeitung 48 (03).

Wild, C. (2007): [Drug Eluting Stents (DES). Update February 27th, 2007. HTA in hospitals]. HTA in hospitals. Vienna, 27.02.2007.

Wild, C. (2007): [Biosimilars]. HTA-Newsletter 54: 2.

Wild, C. (2007): [Growth hormones: Possible late effects]. HTA-Newsletter 54: 3-4.

Wild, C. (2007): [External manual. Part 1]. HTA-Projektbericht 03.

Wild, C. (2007): [Horizon scanning]. ÖKZ: Österreichische Krankenhauszeitung 48 (04): 16.

Wild, C. (2007): [Funding programme of the Vienna Science and Technology Fund (WWTF)]. ÖKZ: Österreichische Krankenhauszeitung 48 (01): 16.

Wild, C. (2007): [Health technology assessment in Austria]. In: Perleth, M. and Busse, R. and Gerhardus, A. and Gibis, B. Health Technology Assessment. Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung: Berliner Schriftenreihe Gesundheitswissenschaften. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft OHG, 37-40. ISBN 978-3-939069-22-5.

Wild, C. (2006): [Foundation of the Ludwig Boltzmann Institute Health Technology Assessment]. Technikfolgen-Abschätzung – Theorie & Praxis 03 (15): 77-79.

Wild, C. (2006): [Artificial nutrition in geriatric care]. HTA-Newsletter 49: 3-4.

Wild, C. (2006): [Technologies for the elderly - gerontechnologies]. Congress of gerontology. Vienna, 09.05.2006.

Wild, C. (2006): [Critical scientific methods for evaluating the effects of medical interventions]. Der Anaesthesist 55 (05): 568-577.

Wild, C. (2006): [Austrian HTA institute founded. The Ludwig Boltzmann Institute of HTA starts working. Editorial]. HTA-Newsletter 47: 1.

Wild, C. (2006): [EUnetHTA: A network of HTA agencies in Europe]. ÖKZ: Österreichische Krankenhauszeitung 47 (11): 17.

Wild, C. (2006): [Generics vs. brand name drugs after patent expiration] . ÖKZ: Österreichische Krankenhauszeitung 47 (10): 16.

Wild, C. (2006): [Non-ionic contrast media]. ÖKZ: Österreichische Krankenhauszeitung 47 (7/8): 16.

Wild, C. (2006): [Foundation of a HTA institute in Austria]. ÖKZ: Österreichische Krankenhauszeitung 47 (6): 16.

Wild, C. (2006): [Acute care for older persons: A multi-disciplinary approach]. ÖKZ: Österreichische Krankenhauszeitung 47 (04): 16.

Wild, C. (2005): [Robot assisted surgery]. ÖKZ: Österreichische Krankenhauszeitung 46 (12): 11.

Wild, C. (1994): [Housing adaptation in Austria and Germany]. Zeitschrift für Gerontologie 27 (06): 381-389.

Wild, C. (1990): [The social implications of the increasing spread of technology in health care]. Journal für Sozialforschung 30 (03): 294-317.

Wild, C. and Adlbrecht, C. (2007): [Radiopharmaceuticals in palliative care]. HTA-Newsletter 58: 2-3.

Wild, C. and Adlbrecht, C. (2007): [Laser vaporisation of benign prostatic hyperplasia]. HTA-Newsletter 56: 2.

Wild, C. and Adlbrecht, C. (2007): [Avastin for age-related macular degeneration]. Rapid Assessment LBI-HTA 02.

Wild, C. and Blagojevic, S. (2016): Annual Report 2015.

Wild, C. and Blagojevic, S. (2015): Annual Report 2014.

Wild, C. and Blagojevic, S. (2014): Annual Report 2013.

Wild, C. and Blagojevic, S. (2013): Annual Report 2012.

Wild, C. and Blagojevic, S. (2012): Annual Report 2011. German Version.

Wild, C. and Emprechtinger, R. (2016): Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke. National Report: German Summary of the correspondent EUnetHTA Report. Decision Support Document 94.

Wild, C. and Gartlehner, G. (2007): [Health technology assessment]. WMW: Wiener Medizinische Wochenschrift 2007. (Submitted)

Wild, C. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Percutaneous aortic valve replacement. Systematic review]. Decision Support Document 18/Update2009.

Wild, C. and Gregor-Patera, N. (2015): HTA-Strategy for Lithuania. Decision Support Document 90a.

Wild, C. and Gregor-Patera, N. and Stricka, M. and Karnickas, L. (2015): Background Analysis for National HTA Strategy for Lithuania: Focus on Medical Devices. Decision Support Document 90.

Wild, C. and Hintringer, K. and Narath, M. (2013): Hadron therapy: Proton and carbon ion therapy - A review of clinical evidence of efficacy, ongoing research and reimbursement. HTA-Projektbericht 74.

Wild, C. and Küllinger, R. and Hintringer, K. (2015): The sponsoring of Austrian CME/continuing medical education for physicians. A systematic analysis of the CME-Database. Rapid Assessment 007a.

Wild, C. and Khan, A. and Erdos, J. (2015): Sponsoring of Patient Initiatives in Austria. Systematic Analysis. Rapid Assessment 007b.

Wild, C. and Langer, T. (2008): EU-wide newsletter on emerging technologies: Informing and supporting health policy early . Health Policy 2008. (In Press)

Wild, C. and Langer, T. (2006): Horizon Scanning System (HSS). An Overview. HTA-Projektbericht 02.

Wild, C. and Langley, T. and Guba, B. and Gartlehner, G. (2008): [Percutaneous aortic valve replacement. Systematic review]. Decision Support Document 18.

Wild, C. and Mathis, S. and Guba, B. and Gartlehner, G. (2008): [Rheopheresis in patients with age-related macular degeneration, sudden hearing loss or tinnitus, diabetes. Systematic review]. Decision Support Document 12.

Wild, C. and Mikl, M. (1996): [Medical genetics in Austria]. Journal für Sozialforschung 36 (01): 87-108.

Wild, C. and Patera, N. (2014): Stereotactic Radiofrequency ablation/ SRFA for hepatocellular carcinoma and liver metastases. Decision Support Document 76.

Wild, C. and Patera, N. and Küllinger, R. and Narath, M. (2015): PET/PET-CT Evidence for need based planning (in oncology indications). HTA-Projektbericht 77.

Wild, C. and Piribauer, F. and Stergner, A. (2009): New influenza (swine flu) – data & facts for decision support. Decision Support Document 35.

Wild, C. and Zechmeister, I. (2007): [Allocation of resources and equity. Editorial]. HTA-Newsletter 59: 1.

Wild, C. and Zechmeister, I. (2007): [Theories of distributional justice in health care and the role of HTA]. Kurswechsel 2: 87-88.

Winkler, R. (2015): Transcatheter mitral valve-in-valve implantation. Decision Support Document 82.

Winkler, R. (2015): Injectable bulking agents for faecal incontinence. Decision Support Document 87.

Winkler, R. (2011): Reorientation of the Austrian parent-child preventive care programme. Part II: International policies, concepts and screening strategies focusing on “normal” and “high-risk” development processes during pregnancy and early childhood until school entry. HTA-Projektbericht 045b.

Winkler, R. (2009): Evaluations of child and adolescent psychiatry. Theory and practice about measurement dimensions, indicators and instruments. HTA Projektbericht 027.

Winkler, R. and Erdos, J. and Wimmer, B. and Piso, B. (2012): Re-orientation of the Austrian parent-child preventive health care programme, Part VI: Health visiting services in the context of health care programmes for pregnant women, parents and children. HTA-Projektbericht 53.

Winkler, R. and Piso, B. (2013): Mental Health Rehabilitation for Children and Adolescents – Systematic overview of evaluation outcomes and instruments. HTA-Projektbericht 67.

Winkler, R. and Reinsperger, I. and Piso, B. (2015): Effects of tangible and intangible incentives on health behavior, Part I: Definitions, theories and models – Part II: Overview of reviews covering 4 health issues. HTA-Projektbericht 83.

Zakosteletzki, L. and Nachtnebel, A. (2012): Horizon Scanning in Oncology - Impact evaluation and environmental analysis. HTA- Projektbericht 61.

Zechmeister, I. (2008): [Modelling-based economic evaluation in the context of Health Technology Assessment: Examples from Austria]. Workshop of the Austrian Society for Operational Research. Vienna, 23.02.2008.

Zechmeister, I. (2008): [Economic evaluation of the vaccination against human papillomavirus in Austria]. Is prevention always better than cure?. Krems, 20.-21.02.2008.

Zechmeister, I. (2008): [Vaccination against HPV in Austria]. HTA-Newsletter 64: 2.

Zechmeister, I. (2008): [HPV-vaccination in Austria. A prediction on long-term effects and costs]. Biomed Austria (Frühling 2008): 8-9.

Zechmeister, I. (2007): [Treatment of mental disorders. Editorial]. HTA-Newsletter 60: 1.

Zechmeister, I. (2007): [Hepatitis C therapy]. HTA-Newsletter 59: 2.

Zechmeister, I. (2007): [Age-related macular degeneration (AMD): Diagnostics]. HTA-Newsletter 56: 2-3.

Zechmeister, I. (2007): [Is it worth investing in mental health promotion and prevention of mental disorders? Evidence from economic evaluations]. In: Meggeneder, O. Tagungsband zur Wissenschaftlichen Jahrestagung der Österreichischen Gesellschaft für Public Health: Linz: Österreichische Gesellschaft für Public Health. (In Press)

Zechmeister, I. (2006): [Back pain: Radiology often unnecessary]. HTA-Newsletter 51: 2.

Zechmeister, I. (2006): [Is it worth investing in mental health promotion and prevention of mental illness? A review of the evidence on economic evaluations]. 9th conference of the Austrian Public Health Association. Linz, 28.-29.09.2006.

Zechmeister, I. (2006): [HPV immunisation: Different strategies]. HTA-Newsletter 50: 3-4.

Zechmeister, I. (2006): [Current guidelines for health economic evaluation. Austria in comparison with Canada. Editorial]. HTA-Newsletter 48: 1.

Zechmeister, I. (2006): [Statins: Economic evaluation]. HTA-Newsletter 48: 2.

Zechmeister, I. (2006): [Cost-effectiveness of statins]. ITA-Newsletter March 2006: 3-3.

Zechmeister, I. (2006): [Women, think economically?! Ambivalences of current economic thinking. The case of health economics]. Beiträge zur Feministischen Theorie und Praxis 68: 115-127.

Zechmeister, I. (2006): [Health policy between 2002 and 2006 – what is the experts’ opinion?]. ÖKZ: Österreichische Krankenhauszeitung 47 (09): 8.

Zechmeister, I. (2005): [Financing health care: Challenges for psychiatry]. ITA-Newsletter December 2005: 4-5.

Zechmeister, I. and Österle, A. (2007): [Informal care of people with mental disorders: Does the Austrian long-term care system provide adequate support?]. Neuropsychiatrie 21 (1): 29-36.

Zechmeister, I. and Freiesleben de Blasio, B. and Radlberger, P. and Wild, C. and Kvas, E. and Garnett, G. and Neilson, A. R. (2007): [Economic evaluation of HPV vaccination in Austria]. HTA-Projektbericht 09.

Zechmeister, I. and Huić, M. (2011): Vascular-Endothelial-Growth-Factor-Inhibitors (anti-VEGF) in the Management of Diabetic Macular Oedema. German version. Decision Support Document 43.

Zechmeister, I. and Huić, M. (2011): Vascular-Endothelial-Growth-Factor-Inhibitors (anti-VEGF) in the Management of Diabetic Macular Oedema. English version. Decision Support Document 43.

Zechmeister, I. and Kilian, R. and Mc Daid, D. (2008): Is it worth investing in mental health promotion and prevention of mental illness? A systematic review of the evidence from economic evaluations. BMC Public Health 08 (20).

Zechmeister, I. and Loibl, T. (2011): Reorientation of the Austrian parent-child preventive care programme. Part III: Financing structures of services and public transfers for parents and young children. HTA-Projektbericht 045c.

Zechmeister, I. and Mathis, S. and Guba, B. and Gartlehner, G. (2008): [LDL apheresis. Systematic review]. Decision Support Document 07.

Zechmeister, I. and Radlberger, P. (2007): [Health economic evaluation]. WMW: Wiener Medizinische Wochenschrift 2007. (Submitted)

Zechmeister, I. and Stollenwerk, B. and Ara, R. and Ward, S. (2008): Statins for the Secondary Prevention of Cardiovascular Diseases: An Analysis of Expected Population Health Gains and Cost-Utility in Austria (Part II of the project 'Statins: A comparison between predicted and actual effects on population health in Austria') . HTA-Projektbericht 018.

Zechmeister, I. and Stollenwerk, B. and Langley, T. (2008): Have Statins Met Our Expectations? A Comparison of Expected Health Gains from Statins with Epidemiological Trends in Austria (Part III of the Project 'Statins: A Comparison Between Predicted and Actual Effects on Population Health in Austria'). HTA-Projektbericht 019.

Zechmeister, I. and Wild, C. and Langer, T. and Koller, D. (2007): [Neonatal care of low-risk newborns by paediatricians. An approach to evidence-based health care planning]. Monatsschrift Kinderheilkunde July 2007. (Submitted)

Zechmeister, I. and Wild, C. and Langer, T. and Koller, D. (2007): [Neonatal care of low-risk newborns. An approach to evidence-based health care planning in Styria] . HTA-Projektbericht 04.

Zechmeister, I. and Winkler, R. (2010): Artificial disc replacement. Decision Support Document 38.

Zechmeister-Koss, I and Fischer, S. (2014): Drug eluting stents for the treatment of peripheral artery disease. Decision Support Document 75.

Zechmeister-Koss, I. (2013): Zostavax® for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA Core Model for Rapid Relative Effectiveness Assessment. Pilot-ID: WP-SA-1. Decision Support Document 73.

Zechmeister-Koss, I. (2012): Standards on how to parameterise models via published literature: Input of the LBI-HTA for IFEDH work package 4. HTA- Projektbericht 58.

Zechmeister-Koss, I. and Fischer, S. and Erdos, J. (2012): Re-orientation of the Austrian parent-child preventive care programme. Part VIII: Review of economic evaluations and budget impact analysis of outreach services and measures to reduce premature birth. HTA-Projektbericht 55.

Zechmeister-Koss, I. and Nachtnebel, A. (2013): Implantation of a lumbar artificial endoprosthesis (anuloplasty/anular repair device). Decision Support Document 65.

Zechmeister-Koss, I. and Reichel, M. (2012): Health status and access to health care of homeless people: A literature review. HTA-Projektbericht 63.

Zechmeister-Koss, I. and Rothschedl, E. (2015): Fully bioresorbable scaffolds for coronary artery disease. Decision Support Document 81.

This list was generated on Tue May 24 07:00:55 2016 CEST.